| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 1,3 M € | -0.8% | 1,3 M € | +6.8% | 1,3 M € | +48.8% | 846,8 k € | +55.9% | 543,3 k € | +41.3% | 384,6 k € | +81.3% | 212,2 k € | +4.1% | 203,8 k € | +257.3% | 57,0 k € | -51.5% | 117,6 k € | -13.4% | 135,9 k € | +49.2% | 91,1 k € | +203.4% | -88,0 k € | -736.6% | 13,8 k € | +163.2% | -21,9 k € | -70.8% | -12,8 k € | +32.8% | -19,0 k € | +91.6% | -227,5 k € | |
| EBITDA | 106,9 k € | -39.9% | 178,0 k € | +98.4% | 89,7 k € | +208.1% | 29,1 k € | -51.1% | 59,5 k € | +129.4% | 25,9 k € | +42.4% | 18,2 k € | -68.9% | 58,5 k € | +142.8% | -136,9 k € | -371.3% | 50,4 k € | -62.8% | 135,4 k € | +53.6% | 88,2 k € | +198.7% | -89,3 k € | -822.3% | 12,4 k € | +153.3% | -23,2 k € | -63.4% | -14,2 k € | +31.1% | -20,6 k € | +91.2% | -233,9 k € | |
| Operating profit | 98,6 k € | -39.8% | 163,9 k € | +118.2% | 75,1 k € | +322.3% | 17,8 k € | -65.4% | 51,4 k € | +149.3% | 20,6 k € | +21.1% | 17,0 k € | -70.7% | 58,1 k € | +142.3% | -137,2 k € | -372.2% | 50,4 k € | -62.8% | 135,4 k € | +53.6% | 88,2 k € | +198.7% | -89,3 k € | -1047.3% | 9,4 k € | +130.7% | -30,7 k € | -41.6% | -21,7 k € | +22.8% | -28,1 k € | +88.5% | -245,0 k € | |
| Profit/loss | 46,0 k € | -57.3% | 107,7 k € | +151.9% | 42,8 k € | +3823.1% | 1,1 k € | -96.6% | 31,7 k € | +60.4% | 19,8 k € | +19.4% | 16,6 k € | -71.4% | 57,9 k € | +140.4% | -143,4 k € | -462.1% | 39,6 k € | -60.4% | 100,0 k € | +13.3% | 88,2 k € | +198.4% | -89,7 k € | -184.1% | 106,6 k € | +454.5% | -30,1 k € | -43.9% | -20,9 k € | -118.0% | 116,2 k € | +147.6% | -243,9 k € | |
| Equity | 346,1 k € | +15.3% | 300,1 k € | +56.0% | 192,4 k € | +28.6% | 149,6 k € | +0.7% | 148,6 k € | +27.2% | 116,8 k € | +20.4% | 97,1 k € | +20.6% | 80,5 k € | +256.0% | 22,6 k € | -86.4% | 166,0 k € | +31.3% | 126,4 k € | +377.8% | 26,5 k € | +142.8% | -61,8 k € | -321.3% | 27,9 k € | +135.5% | -78,7 k € | -61.9% | -48,6 k € | -75.4% | -27,7 k € | +80.7% | -143,9 k € | |
| Total assets | 673,1 k € | +9.6% | 613,9 k € | +50.8% | 407,1 k € | +16.1% | 350,7 k € | +22.2% | 286,9 k € | -1.1% | 290,2 k € | +52.5% | 190,3 k € | +31.5% | 144,7 k € | -47.0% | 272,8 k € | +10.6% | 246,8 k € | +20.4% | 205,0 k € | +68.6% | 121,6 k € | -2.9% | 125,3 k € | +104.6% | 61,2 k € | +16.1% | 52,7 k € | -34.2% | 80,1 k € | -21.9% | 102,6 k € | +52.6% | 67,2 k € | |
| Cash | 57,7 k € | -51.3% | 118,4 k € | +9.2% | 108,4 k € | +51.1% | 71,8 k € | +184.7% | 25,2 k € | -74.2% | 97,8 k € | +395.4% | 19,7 k € | +40.9% | 14,0 k € | +6.3% | 13,2 k € | -86.4% | 96,7 k € | +161.3% | 37,0 k € | +274.4% | 9,9 k € | -90.1% | 99,8 k € | +298.3% | 25,1 k € | +51.0% | 16,6 k € | -37.9% | 26,7 k € | -11.4% | 30,1 k € | -27.6% | 41,6 k € | |
| Debts | 327,0 k € | +4.2% | 313,8 k € | +47.3% | 213,1 k € | +6.0% | 201,0 k € | +45.3% | 138,3 k € | -20.2% | 173,4 k € | +85.9% | 93,2 k € | +45.4% | 64,1 k € | -74.4% | 250,2 k € | +210.0% | 80,7 k € | +2.8% | 78,6 k € | -17.4% | 95,1 k € | -49.1% | 187,0 k € | +461.6% | 33,3 k € | -74.7% | 131,4 k € | +2.1% | 128,7 k € | -0.7% | 129,7 k € | -38.5% | 211,0 k € | |
| Staff | 5,8 | 5,5 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||
Public limited company · Molenbeek-Saint-Jean · incorporated on 12/03/2007 · 5,8 ETP
Public limited company profitable and well capitalised. Cash position declining (-51.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
bioprojet benelux is a Public limited company incorporated in 2007. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Molenbeek-Saint-Jean. It employs on average 5,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette